StockData
Evaxion A/S logo

Evaxion A/S (EVAX) income statement

EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$2.54−0.24 (-8.63%)

Close on Nov 18, 2026Market cap $21.18MP/E –Yield –

Evaxion A/S income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin
–
Operating margin
-122.7%
Net margin
-102.4%
Return on equity, FY2025
–

Financial strength

Current ratio
5.06
Debt to equity
–
Debt to assets
27.4%
Cash to current liabilities
446.9%

Valuation

P/E ratio
–
Price to sales
2.81
Price to book
–
Dividend yield
–

See a number that looks wrong?